Figure 2
After 20 h incubation of cells at 37°C (16 h incubation prior to the addition of resazurin and further incubation for 4 h), the blue color shows no growth, whereas the pink wells represent growing cells (B = MOPS minimal media as sterility control, U = untreated cells). Numbers refer to concentrations or exposure as indicated. (A) The EtBr MIC shows a ≈64-fold increase in sensitivity when the TolC pump is knocked out. (B) UV irradiation MIC shows a ≈32-fold increase in sensitivity to UV with the uvrA knockout. (C) 4-NQO MIC shows a 30-µM MIC for the compound, which decreased eightfold in the uvrA knockout, confirming the compound to be a substrate for NER. (D) ATBC MIC, the MIC is > 125 µM for both strains used, indicating ATBC is nontoxic. The experiments were performed in triplicate on three independent days. No appreciable difference was identified among the replicates. A black and white version of this figure has been placed in the Supplementary material for improved visual accessibility (Supplementary Figure S1).
Determining MIC

After 20 h incubation of cells at 37°C (16 h incubation prior to the addition of resazurin and further incubation for 4 h), the blue color shows no growth, whereas the pink wells represent growing cells (B = MOPS minimal media as sterility control, U = untreated cells). Numbers refer to concentrations or exposure as indicated. (A) The EtBr MIC shows a ≈64-fold increase in sensitivity when the TolC pump is knocked out. (B) UV irradiation MIC shows a ≈32-fold increase in sensitivity to UV with the uvrA knockout. (C) 4-NQO MIC shows a 30-µM MIC for the compound, which decreased eightfold in the uvrA knockout, confirming the compound to be a substrate for NER. (D) ATBC MIC, the MIC is > 125 µM for both strains used, indicating ATBC is nontoxic. The experiments were performed in triplicate on three independent days. No appreciable difference was identified among the replicates. A black and white version of this figure has been placed in the Supplementary material for improved visual accessibility (Supplementary Figure S1).

Close Modal

or Create an Account

Close Modal
Close Modal